PULMONARY FIBROSES, IDIOPATHIC

Clinical trials for PULMONARY FIBROSES, IDIOPATHIC explained in plain language.

Never miss a new study

Get alerted when new PULMONARY FIBROSES, IDIOPATHIC trials appear

Sign up with your email to follow new studies for PULMONARY FIBROSES, IDIOPATHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Inhaled molecule aims to halt lung scarring in first human tests

Disease control Completed

This early-stage trial tests an inhaled drug called CMR316 in healthy volunteers and people with idiopathic pulmonary fibrosis (IPF), a disease that causes progressive lung scarring. The study's main goal is to check the drug's safety and how the body processes it. Participants r…

Matched conditions: PULMONARY FIBROSES, IDIOPATHIC

Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control

Last updated Jul 11, 2026 00:00 UTC

PULMONARY FIBROSES, IDIOPATHIC

Get alerted when new PULMONARY FIBROSES, IDIOPATHIC trials appear

Inhaled molecule aims to halt lung scarring in first human tests